Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Long-Term Investments (2016 - 2023)

AtriCure (ATRC) has disclosed Long-Term Investments for 11 consecutive years, with $7.6 million as the latest value for Q2 2023.

  • On a quarterly basis, Long-Term Investments fell 88.18% to $7.6 million in Q2 2023 year-over-year; TTM through Jun 2023 was $7.6 million, a 88.18% decrease, with the full-year FY2022 number at $51.5 million, down 50.63% from a year prior.
  • Long-Term Investments was $7.6 million for Q2 2023 at AtriCure, down from $25.6 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $105.1 million in Q3 2021 to a low of $7.6 million in Q2 2023.
  • A 5-year average of $40.7 million and a median of $23.0 million in 2019 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: skyrocketed 672.59% in 2022, then tumbled 88.18% in 2023.
  • AtriCure's Long-Term Investments stood at $12.7 million in 2019, then increased by 11.86% to $14.2 million in 2020, then surged by 635.91% to $104.3 million in 2021, then tumbled by 50.63% to $51.5 million in 2022, then crashed by 85.25% to $7.6 million in 2023.
  • Per Business Quant, the three most recent readings for ATRC's Long-Term Investments are $7.6 million (Q2 2023), $25.6 million (Q1 2023), and $51.5 million (Q4 2022).